The Association of High Lipoprotein(a) Concentration and Risk of Ischaemic Stroke in Atrial Fibrillation Patients
DOI: https://doi.org/10.2147/ijgm.s449400
IF: 2.145
2024-05-08
International Journal of General Medicine
Abstract:Siyi Zhang, 1, 2, &ast Yue Zhou, 1, &ast Jinghui Wang, 2 Qingan Fu, 1 Tianzhou Shen, 2 Guanrui Pan, 2 Renfei Luo, 1 Xinlei Yang, 3 Long Jiang, 1 Hui Hu 4 1 Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China; 2 Department of Clinical Medicine, Queen Mary School of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China; 3 Department of Biobank Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China; 4 Department of Medical Big Data Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Long Jiang, Department of Cardiovascular Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China, Tel +86-13767026990, Email Hui Hu, Department of Medical Big Data Center, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China, Tel +86-13576978125, Email Background: Lipoprotein(a) [Lp(a)] is a well-established risk factor for ischaemic stroke (IS). It is unclear whether Lp(a) is associated with IS in patients with atrial fibrillation (AF). The aim of this study is to explore the association between the concentration of Lp(a) and the risk of IS in AF patients, hope to find the potential risk factor for the IS in AF patients. Methods: This study is a retrospective cohort study. The screened AF patients between January 2017 and July 2021 were matched at 1:1 by the propensity score matching (PSM) method in the Second Affiliated Hospital of Nanchang University. Associations between Lp(a) and ischaemic stroke were analysed using logistic regression models, stratified analysis and sensitivity analysis. Statistical analyses were conducted using IBM SPSS software. Results: The number of enrolled participates is 2258, which contains 1129 non-AF patients and 1129 AF patients. Among IS patients, the median Lp(a) concentration was higher than that of controls (17.03 vs. 15.36 mg/dL, P = 0.032). The Spearman rank-order correlation coefficients revealed significant positive relationships between IS and Lp(a) (P = 0.032). In addition, a significant increase in IS risk was associated with Lp(a) levels > 30.00 mg/dL in unadjusted model [OR:1.263, 95% CI(1.046– 1.523), P = 0.015], model 1 [OR:1.284, 95% CI(1.062,1.552), P = 0.010], model 2 [OR: 1.297, 95% CI(1.07,1.573). P = 0.008], and model 3 [OR: 1.290, 95% CI (1.064, 1.562). P = 0.009]. The stratified analysis indicated that this correlation was not affected by female sex [1.484 (1.117, 1.972), P = 0.006], age ≤ 60 [1.864 (1.067-3.254), P=0.029], hypertension [1.359 (1.074, 1.721), P = 0.011], or non-coronary heart disease (CHD) [1.388 (1.108, 1.738), P = 0.004]. Conclusion: High levels of Lp(a) were significantly related to IS in AF patients and may be a potential risk factor in the onset of an IS in AF patients. Keywords: ischaemic stroke, Lipoprotein(a), atrial fibrillation, risk factor, retrospective cohort study Graphical Stroke is a clinical syndrome with high incidence, recurrence, and mortality. It is classified as ischaemic and haemorrhagic stroke. Ischaemic stroke (IS) is caused by decreased blood flow in the brain due to blockage of arteries, resulting in loss of brain cells. 1 Incident stroke cases in 2019 numbered 12.2 million, while prevalent strokes numbered 101 million. Therefore, stroke remains a worldwide second most common cause of death, and IS accounts for 62.4% of all incident strokes. 2 For patients with atrial fibrillation (AF), the risk of stroke is 5-fold higher, accounting for more than 79% of cardiogenic strokes. 3,4 IS caused by AF is more severe, with more complications and poorer prognosis. 5 There are various risk factors that influence the incidence of stroke among individuals with AF, including age, hypertension, diabetes, embolism, and ventricular insufficiency. 6–8 The guidelines suggest that AF patients with risk factors for IS should be given regular anticoagulant therapy to prevent its occurrence. 9 Lipoprotein(a), a low-density lipoprotein cholesterol-like molecule, is bound to apolipoprotein(a). Lp(a) functions against vascular inflammation and atherosclerosis lesions. 10 Lp(a) can promote thrombosis by influencing platelets and the coagulation system, resulting in -Abstract Truncated-
medicine, general & internal